Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and Dexmedetomidine for Chronic Postsurgical Pain After Pancreatic Surgery
NCT07888413Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Dec 2026
- Primary completion
- Nov 2028
01
Overview
Phase 4, randomised, double-blind trial in chronic pain comparing Esketamine + Dexmedetomidine with Saline Placebo (2 arms). Primary endpoint: Incidence of Chronic Pain at 3 Months After Pancreatic Surgery. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT07888413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888413.